Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug and Talk Therapy for Fibromyalgia
NCT01038323Phase 4Completed
- Sponsor
- Indiana University
- Start
- Dec 2009
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of milnacipran in fibromyalgia (FM) (3 arms), sponsored by Indiana University. Primary endpoint: Change in Weekly Average Pain Intensity at 21 weeks. Started Dec 2009; status: completed.
02
Drugs
milnacipran
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT01038323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01038323.